Ligand Pharmaceuticals reported $40.99M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acorda Therapeutics ACOR:US $ 22.25M 5.68M
Agenus AGEN:US $ 18.9M 6.5M
Amgen AMGN:US $ 5084M 407M
Anika Therapeutics ANIK:US $ 24.86M 3.06M
Baxter International BAX:US $ 1457M 107M
Bristol Myers Squibb BMY:US $ 9210M 33M
Clovis Oncology CLVS:US $ 22.93M 1.91M
Eli Lilly And LLY:US $ 5057.5M 680.4M
Gilead Sciences GILD:US $ 4818M 348M
GlaxoSmithKline GSK:LN 4.79B 1.34B
Glaxosmithkline GSK:US $ 4793M 1342M
Harsco HSC:US $ 77.85M 2.08M
Insmed INSM:US $ 48.83M 7.91M
Karyopharm Therapeutics KPTI:US $ 38.74M 7.5M
Lannett LCI:US $ 3.08M 2.63M
MacroGenics MGNX:US 23.6M 12.55M
Merk MRK:US $ 10895M 328M
Pacira Pharmaceuticals PCRX:US $ 118.78M 3.13M
Pfizer PFE:US $ 19071M 3420M
Teva Pharmaceutical Industries TEVA:US $ 1828M 26M
Veracyte VCYT:US $ 47.83M 3.76M